Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00347594 · ClinicalTrials.gov registry record · NA

A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)

A NA study of Healthy, sponsored by Bausch & Lomb Incorporated.

Completed
Registry status
NA
Development phase
76
Enrollment target
1
Study location

NCT00347594 is a NA study of Healthy that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 76 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00347594, a NA study of Healthy, has completed, sponsored by Bausch & Lomb Incorporated.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to measure the aberrations, corneal surface topography and pachymetry of normal human eyes with the NGDI.

Conditions Studied

Healthy

Interventions

  • DEVICE Next Generation Diagnostic Instrument (NGDI)
  • DEVICE Zyoptix Diagnostic Workstation (ZDW)

Study Locations (1)

New York

  • Bausch & Lomb - Rochester

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2005-08
Est. Completion 2006-09
Phase NA

Sponsor

Bausch & Lomb Incorporated

174 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00347594

The ClinicalTrials.gov registry entry for NCT00347594 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Next Generation Diagnostic Instrument (NGDI) is the first listed.

NCT00347594 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00347594 about?

NCT00347594 is a clinical study titled "A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)". The purpose of this study is to measure the aberrations, corneal surface topography and pachymetry of normal human eyes with the NGDI.

What is the current status of trial NCT00347594?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2005-08. Estimated completion is 2006-09.

What conditions does trial NCT00347594 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00347594?

The interventions under investigation include: Next Generation Diagnostic Instrument (NGDI) (DEVICE), Zyoptix Diagnostic Workstation (ZDW) (DEVICE).

Who is sponsoring clinical trial NCT00347594?

This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00347594 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.